Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis

Liver International

Volumn 25, Issue 1, 2005, Pages 41-48

  Kayali, Zeid ^a   Ranguelov, Rostislav ^b   Mitros, Frank ^b   Shufelt, Chrisandra ^a   Elmi, Farshad ^b   Rayhill, Stephen C ^b   Schmidt, Warren N ^b,c   Brown, Kyle E ^b,c,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Department of Medicine   (United States)

Author keywords

Child Pugh score; Ferritin; Hemosiderin; Iron; MELD score

Indexed keywords

IRON;

ADULT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; FEMALE; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER HEMOSIDEROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; REVIEW; SCORING SYSTEM; STAINING; SURVIVAL;

FEMALE; HEMOSIDEROSIS; HUMANS; IRON; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STAINING AND LABELING; SURVIVAL RATE;

EID: 14544292424     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01022.x     Document Type: Review

References (29)

1. Bonkovsky H L, Banner B F, Lambrecht R W, Rubin R B. Iron in liver diseases other than hemochromatosis. Semin Liver Dis 1996; 16: 65-82.
2. Barton A L, Banner B F, Cable E E, Bonkovsky H L. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol 1995; 103: 419-24.
3. Beinker N K, Voigt M D, Arendse M, Smit J, Stander I A, Kirsch R E. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 1996; 25: 633-8.
4. Hézode C, Cazeneuve C, Coué O, et al. Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. J Hepatol 1999; 31: 979-84.
5. Sartori M, Andorno S, Rigamonti C, Grossini E, Nicosia G, Boldorini R. Chronic hepatitis C is mild in menstruating women. J Gastroenterol Hepatol 2000; 15: 1411-7.
6. Negro F, Samii K, Rubbia-Brandt L, et al. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis. J Med Virol 2000; 60: 21-7.
7. Thorburn D, Curry G, Spooner R, et al. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 2002; 50: 248-52.
8. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput J C, Naveau S. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002; 35: 635-8.
9. George D K, Goldwurm S, Macdonald G A, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-8.
10. Ludwig J, Hashimoto E, Porayko M, Moyer T, Baldus W. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997; 112: 882-8.
11. Deugnier Y, Turlin B, Le Quilleuc D, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol 1997; 21: 669-75.
12. Cotler S J, Bronner M P, Press R D, Carlson T H, Perkins J D, Emond M J, Kowdley K V. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998; 29: 257-62.
13. Malinchoc M, Kamath P, Gordon F, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.
14. Scheuer P J, Williams R, Muir A R. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 1962; 84: 53-63.
15. Witte D L, Crosby W H, Edwards C Q, Fairbanks V F, Mitros F A. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996; 245: 139-200.
16. Zimmerman H J, Chomet B, Kulesh M H, Mcwhorter C A. Hepatic hemosiderin deposits. Arch Int Med 1961; 107: 74-83.
17. Stuart K A, Fletcher L W, Clouston A D, et al. Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation. Hepatology 2001; 32: 1200-7.
18. Ganne-Carrié N, Christidis C, Chastang C, et al. Liver iron is predictive of death in alcoholic cirrhosis; a multivariate study of 229 consecutive patients with alcoholic and/or hepatitic C virus cirrhosis: a prospective follow up study. Gut 2000; 46: 277-82.
19. Deugnier Y, Turlin B, Powell L, et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 1993; 17: 30-4.
20. Brissot P, Bourel M, Herry D, et al. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 1981; 80: 557-65.
21. Chapman R W, Morgan M Y, Laulicht M, Hofbrand A V, Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci 1982; 27: 909-16.
22. Milman N, Graudal N, Hegnhøj J, Christoffersen P, Strandberg Pedersen N. Relationships among serum iron status markers, chemical and histochemical liver iron content in 117 patients with alcoholic and nonalcoholic hepatic disease. Hepato-Gastroenterology 1994; 41: 20-4.
23. Brunt E M, Olynyk J K, Britton R S, Janney C G, Di Bisceglie A M, Bacon B R. Histological evaluation of iron in liver biopsies: relationship to HFE mutations. Am J Gastroenterol 2000; 95: 1788-93.
24. Aruoma O I, Bomford A, Polson R J, Halliwell B. Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Blood 1988; 72: 1416-9.
25. Weiss G. Iron and immunity: a double-edged sword. Eur J Clin Invest 2002; 32(Suppl. 1): 70-8.
26. Hirayama M, Kohgo Y, Kondo H, et al. Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron. Hepatology 1993; 18: 874-80.
27. Hanson E S, Leibold E A. Regulation of iron regulatory protein 1 during hypoxia and hypoxia/reoxygenation. J Biol Chem 1998; 273: 7588-93.
28. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia and inflammation. J Clin Invest 2002; 110: 1037-44.
29. Stuart K A, Anderson G J, Frazer D M, et al. Increased duodenal expression of divalent metal transporter 1 and iron-regulated gene 1 in cirrhosis. Hepatology 2004; 39: 492-9.